Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Amyotrophic Lateral Sclerosis
- Phase
- Phase 2 / Phase 3
- Status
- Recruiting
- Enrollment
- 246 Estimated
- Expected completion
- Sep 2027
- Record updated
- Oct 6, 2026
- Lead sponsor
- Mario Negri Institute for Pharmacological Research